L834-1051 Screening compound: N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}furan-2-carboxamide

L834-1051 Screening compound: N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}furan-2-carboxamide
L834-1051 Screening compound: N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}furan-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L834-1051
N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}furan-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L834-1051

Molecular Formula

C19H18N4O5 (C19 H18 N4 O5)

Compound Name

N-{[3-(3-oxo-4-propyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}furan-2-carboxamide

IUPAC name

N-{[3-(3-oxo-4-propyl-34-dihydro-2H-14-benzoxazin-6-yl)-124-oxadiazol-5-yl]methyl}furan-2-carboxamide

SMILES

CCCN1c(cc(cc2)-c3noc(CNC(c4ccco4)=O)n3)c2OCC1=O

InChI

InChI=1S/C19H18N4O5/c1-2-7-23-13-9-12(5-6-14(13)27-11-17(23)24)18-21-16(28-22-18)10-20-19(25)15-4-3-8-26-15/h3-6,8-9H,2,7,10-11H2,1H3,(H,20,25)

InChI Key

UFDZYRUXTNOXFW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478938

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.38

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.258

Distribution Coefficient, logD

2.258

Water Solubility, LogSw

-2.77

Polar Surface Area

88.653

Acid Dissociation Constant (pKa)

12.24

Base Dissociation Constant (pKb)

-0.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

L834-1051 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L834-1051 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L834-1051?
Check Price and Availability of L834-1051, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L834-1051 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L834-1051
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L834-1051
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L834-1051 available by request